Maverick Simulation Solutions Unlisted Shares: Business, Financials & Key Risks

Here is a summary of the video on Maverick Simulation Solutions by UnlistedKraft:

Company Background

• Business Overview: Maverick manufactures simulation products and anatomical models for medical education and healthcare, helping train doctors, nurses, and students using realistic scenarios.
• Timeline: Incorporated in September 2023, the company signed a business transfer agreement with Maverick Solutions Inc. in December 2023.

Financial Highlights (FY24 vs FY25)

• Revenue Growth: Jumped significantly from ₹14.22 Crore in FY24 to ₹136.31 Crore in FY25.
• Profit After Tax: Grew from ₹0.95 Crore in FY24 to ₹47.82 Crore in FY25.
• Earnings Per Share (EPS): Increased from 3.95 to 97.32.

Key Risk Factors & Analysis

• Negative Operating Cash Flow: Despite reporting ₹47.82 Crore in profit, operating cash flow stands at -₹21 Crore, indicating that reported profits haven't yet converted into actual cash.
• Surging Trade Receivables: Uncollected payments from customers skyrocketed from ₹5.13 Crore in FY24 to ₹105.39 Crore in FY25, creating a ₹100.25 Crore negative cash impact.
• Rising Debt & Finance Costs: Total borrowings increased from ₹7.85 Crore in FY24 to ₹23.03 Crore in FY25, pushing finance costs up from ₹0.15 Crore to ₹2.84 Crore.
• Valuation: Maverick manufactures simulation unlisted market indicative price of ₹2,750 per share against an FY25 EPS of 97.32, the implied Price-to-Earnings (P/E) ratio is roughly 28.3x.

Bottom Line: While the company shows strong top-line and bottom-line expansion, investors should closely monitor receivables collection, cash flow generation, and debt levels before investing.